Mukherjee, Abir http://orcid.org/0000-0001-5234-0136
Bezwada, Divya http://orcid.org/0000-0002-5434-2976
Greco, Francesco http://orcid.org/0000-0001-7059-528X
Zandbergen, Malu
Shen, Tong
Chiang, Chun-Yi http://orcid.org/0009-0008-6983-0252
Tasdemir, Medine http://orcid.org/0000-0001-5137-7308
Fahrmann, Johannes
Grapov, Dmitry http://orcid.org/0000-0002-7204-3128
La Frano, Michael R. http://orcid.org/0000-0002-2269-1688
Vu, Hieu S.
Faubert, Brandon http://orcid.org/0000-0002-2886-886X
Newman, John W. http://orcid.org/0000-0001-9632-6571
McDonnell, Liam A. http://orcid.org/0000-0003-0595-9491
Nezi, Luigi http://orcid.org/0000-0002-4670-7656
Fiehn, Oliver http://orcid.org/0000-0002-6261-8928
DeBerardinis, Ralph J. http://orcid.org/0000-0002-2705-7432
Lengyel, Ernst http://orcid.org/0000-0001-8624-1507
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35CA264619, R01CA169604)
Ovarian Cancer Research Fund (372898)
United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (W81XWH2110376)
Article History
Received: 5 October 2021
Accepted: 27 July 2023
First Online: 31 August 2023
Competing interests
: There are no potential conflicts of interest. E.L. received funding from Abbvie and Arsenal Bioscience for preclinical research studies unrelated to the submitted paper.